The Toxicity of Synthetic Heparin Substitutes

References

• Astrup T., Galsmar I., Volkert M. Polysaccharide Sulphuric Acids as Anticoagulants. Acta physiol. Scandinav. 1944; 8: 215
   Google Scholar
• Astrup T., Piper J. Cellulose Sulphuric Acids as Anticoagulants. Acta physiol. Scandinav. 1945a; 9: 351
   Google Scholar
• Astrup T., Piper J. Om de syntetiske, koagulationshemmende Polysaccharidsvovlsyreesteres Egenskaber, Virkning i Organismen og mulige Betydning for Emboliproblemet. Nord. med. 1945b; 28: 3405
   Google Scholar
• Astrup T., Piper J. Interaction Between Fibrinogen and Polysaccharide Polysulphuric Acids. Acta physiol. Scandinav. 1946; 11: 211
   Google Scholar
• Balazs E. A., Högberg B., Laurent T. C. The Biological Activity of Hyaluron Sulphuric Acid. Acta physiol. Scandinav. 1951; 23: 168
   PubMedGoogle Scholar
• Baronofsky I. D., Quick A. J. Heparin and the Agglutination of Platelets in Vitro. Proc. Soc. Exper. & Biol. Med. 1943; 53: 173
   Google Scholar
• Barsøe O. C, Selsø S. On the Antiocoagulant Action of Synthetic Polysaccharide Polysulphuric Acids. Acta Pharmacol, et toxicol. 1946; 2: 367
   PubMedGoogle Scholar
• Bergström S. Über die Wirkungsgruppe des Heparins. Naturwiss. 1935; 23: 706
   Google Scholar
• Über Polysaccharidesterschwefelsäuren mit Heparinwirkung. Ztschr. f. physiol. Chem. 1936; 238: 163
   Google Scholar
• Copley A. L, Robb T. P. Studies on Platelets. II. The Effect of Heparin on the Platelet Count in Vitro. Am. J. Clin. Path. 1942a; 12: 416
   Google Scholar
• Copley A. L., Robb T. P. Studies on Platelets. III. The effect of Heparin in Vivo on the Platelet Count in Mice and Dogs. Am. J. Clin. Path. 1942b; 12: 563
   Google Scholar
• Fidlar E., Jaques L. B. The Effect of Commercial Heparin on the Platelet Count. J. Lab. & Clin. Med. 1948; 33: 1410
   PubMed Web of Science ®Google Scholar
• Grönwall A., Ingelman B., Mosimann H. A Dextran Sulphuric Acid Ester with Heparin Activity. Uppsala Läkarefören. Förhandl. N. F. 1945; 50: 397
   Google Scholar
• Halse Th. Fortschritte bei der Behandlung der akuten Thrombose, Thrombophlebitis und Embolic mit Heparin, Dicumarol und Thrombocid. Deutsche Med. Wchnschr. 1949; 74: 1326
   Web of Science ®Google Scholar
• Heparin und Heparinoide. Dicumarol. S. Hirzel, Stuttgart 1950
   Google Scholar
• Halse Th., Schmitz M. Thrombostatische und Thrombolytische Wirkung eines synthetischen Heparinpräparates. Med. Klin. 1949; 44: 857
   Google Scholar
• Husemann E. V., Kaulla K. N., Kapesser R. Über blutgerinnungshemmende Substanzen. Ztschr. f. Naturforsch. 1946; 1: 584
   Web of Science ®Google Scholar
• Ingehnan B. An Inulin Sulphuric Acid Ester with Antiocoagulant Activity. Arkiv Kemi, Mineral. Geol. 1946; 24 B(No. 5)
   Google Scholar
• Kaulla V. K. N., Husemann E. Über Beziehun-gen der Molekülgrösse und -gestalt zur physiologischen Wirkung. Experientia 1946; 2: 223
   Google Scholar
• Meunier P., Molho D., Moraux J., Cotte J. Apparation du pouvoir anticoagulant au cours de l'esterification sulfurique d'un polysaccharide à effet primitif coagulant, l'alginate de Na. Compt. rend. Soc. de Biol. 1950; 144: 141
   Google Scholar
• Pantlitschko M., Schmid J., Seelich F., Kaiser E. Über die blutgerinnungshemmende Eigen-schaft sulfurierter Hyaluronsäure. Österreich. Akad. Wissenschaften. Math.-naturwiss. Klasse, Sitzungsberichte, Abt. II b. Chemie 1951; 160: 380
   Google Scholar
• Piper J. Influence of Synthetic Polysaccharid Sulphuric Acid Esters on the Thrombocytes in vivo and in vitro. Acta physiol. Scandinav. 1945a; 9: 28
   Google Scholar
• Farmakologiske Undersøgelser over syntetiske koagulationshaemmende Stoffer af Heparin-gruppen. University of Copenhagen. 1945b, Thesis
   Google Scholar
• The anticoagulant effect of heparin and synthetic polysaccharide-polysulphuric acid esters. Acta Pharmacol, et toxicol. 1946a; 2: 138
   PubMedGoogle Scholar
• Toxicology of Synthetic Polysaccharide Poly-sulphuric Acid Esters. Acta Pharmacol, et toxicol. 1946b; 2: 317
   PubMedGoogle Scholar
• The Fate of Heparin in Rabbits after Intravenous Injection. Filtration and Tubular Secretion in the Kidney. Acta Pharmacol, et toxicol. 1947; 3: 373
   PubMedGoogle Scholar
• Quick A. J., Shanberge J. N., Stefanini M. The Effect of Heparin on Platelets in Vivo. Journ. Lab. & Clin. Med. 1948; 33: 1424
   PubMed Web of Science ®Google Scholar
• Ricketts C. R. Chemistry of Dextran and its Derivatives. Proc. Roy. Soc. Med. 1951; 44: 558
   PubMedGoogle Scholar
• Dextran Sulphate. A Synthetic Analogue of Heparin. Biochem. J. 1952; 51: 129
   PubMed Web of Science ®Google Scholar
• Schmid I. Über ein neues Heparinoid. Troisième congrès de la société. Internationale européenne d'hématologie. Rome 1951; 98, Programme
   Google Scholar
• Schulze W. Zur thrombostatischen Wirkung von Xylanschwefelsáureester. Deutsche Gesund-heitswesen 1950; 5: 1392
   PubMedGoogle Scholar
• Seifter J., Begany A. J. Studies on the action of a synthetic heparinoid. Am. J. M. Sc. 1948; 216: 234
   Google Scholar
• Solandt D. Y., Best C. H. Time-Relations of Heparin Action on Blood-Clotting and Platelet Agglutination. Lancet 1940; 238: 1042
   Google Scholar
• Sorenson C. W., Seifter J., Wright I. S. A new synthetic anticoagulant (heparinoid). Preliminary report of its action in humans. Bull. New York. Acad. Med. 1949; 25: 448
   PubMedGoogle Scholar
• Sorenson C. W., Wright I. S. Studies with a new synthetic anticoagulant. “Blood clotting and allied problems”, Transactions of the Second Conference, New York, 1949, 221
   Google Scholar
• Sorenson C. W., Wright I. S. Summary of experiences with the anticoagulant, Paritol (32 cases). “Blood clotting and allied problems”. Transactions of the Third Conference, New York, 1950a, 83
   Google Scholar
• Sorenson C. W., Wright I. S. A synthetic anticoagulant: A polysulphuric acid ester of polyanhydromannuronic acid (Paritol). Experience with its use in man. Circulation 1950b; 2: 658
   PubMed Web of Science ®Google Scholar
• Walton K. Experiments with Dextran Sulphate as an Anticoagulant. Proc. Roy. Soc. Med. 1951; 44: 563
   PubMedGoogle Scholar
• The Biological Behaviour of a New Synthetic Anticoagulant (Dextran Sulphate) Possessing Heparin-Like Properties. Brit. J. Pharmacol. Chemotherapy. 1952; 7: 370
   PubMed Web of Science ®Google Scholar